Directa Plus PLC - producer and supplier of graphene nanoplatelets - Notes good progress in second half. As a result, is confident of achieving total revenue for 2020 of about EUR6.0 million, exceeding current consensus market expectations. Recorded EUR2.3 million in revenue in 2019.
"This improvement in trading performance has been primarily driven by the sales of G+ enhanced face masks, including Co-Masks, which have proven very popular with both individual and corporate customers and have generated strong demand. The strengthening performance of Setcar, the Environmental division, has also contributed to the improved revenue expectations for the current year," company adds.
Chief Executive Giulio Cesareo says firm is "gaining momentum" in each of its four key verticals.
"This has been an unusual and challenging year, but we are pleased with the growth that we have achieved and the commercial progress we have made despite the worldwide economic uncertainty caused by the coronavirus," Cesareo adds.
Current stock price: 81.99 pence
Year-to-date change: up 12%
By Paul McGowan; paulmcgowan@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Directa Plus (DCTA)